GSK, every mention
8 scenes · ← back to GSK
tap a year for its mentions
every year anyone Vijay Pande 8Kim Branson 8
Verbatim, from the transcripts: the passages where GSK comes up
AI in Pharmaceutical R&D with Kim Branson
- ▶ 0:14 Vijay Pande Today, we have, uh, Kim Branson, the SVP and Global Head of AI and Machine Learning for GSK.
- ▶ 4:16 Vijay Pande So, what drew you to GSK? 6 times in the scene
- ▶ 12:49 Kim Branson Even a GSK professorship of computational pathology, a guy called Nassir Rajput, um, who works with us closely.
- ▶ 14:04 Vijay Pande Well, so for the audience, like, could you give a sense for, like, the delta between, like, what you can do with ML now and TSK versus maybe the way this would have been done 10 years ago?
- ▶ 18:15 Kim Branson GSK won't deal with that deal with you, just to be clear.
- ▶ 24:11 Kim Branson Anyone across GSK.
- ▶ 24:44 Kim Branson I think we'll have, um, multiple, we'll call computational biomark, computational methods, um, so every, every software, every drug VSK will launch will have software that sits around it. 3 times in the scene
- ▶ 28:34 Kim Branson That's where I think that we either need to create larger, um, public-private consortia or public thing, like, you know, what everybody wants to do is like, oh, can I have all GSK's clinical data for this trial, and I'm a different company? 2 times in the scene